Picture of Ceryvyn Therapeutics logo

CYV — Ceryvyn Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Opthea Logs FY Prelim Loss Attributable $162.8 Mln

Aug 29 (Reuters) - Opthea Ltd OPT.AX:

FY PRELIM LOSS ATTRIBUTABLE $162.8 MILLION

FY PRELIM REVENUES FROM ORDINARY ACTIVITIES $5.6 MILLION

Further company coverage: OPT.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ceryvyn Therapeutics

See all news